Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases☆

被引:0
作者
van Schaik, Jeroen E. [1 ]
van der Vegt, Bert [2 ]
Slagter-Menkema, Lorian [2 ]
Hanemaaijer, Saskia H. [1 ]
Halmos, Gyorgi B. [1 ]
Witjes, Max J. H. [3 ]
van der Laan, Bernard F. A. M. [1 ]
Fehrmann, Rudolf S. N. [4 ]
Oosting, Sjoukje F. [4 ]
Plaat, Boudewijn E. C. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head & Neck Surg, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
关键词
Head and neck squamous cell carcinoma; Immunohistochemistry; EGFR; GPNMB; VEGF; EXPRESSION; SURGERY;
D O I
10.1016/j.amjoto.2024.104298
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: To investigate glycoprotein nonmetastatic melanoma protein B (GPNMB) and vascular endothelial growth factor (VEGF) as potential fluorescent imaging markers by comparing their protein expression to epidermal growth factor receptor (EGFR). Materials and methods: Thirty-eight paired samples of untreated head and neck squamous cell carcinoma (HNSCC) primary tumours (PT) and corresponding synchronous lymph node metastases (LNM) were selected. After immunohistochemical staining, expression was assessed and compared by the percentage of positive tumour cells. Data were analysed using the Mann-Whitney test, effect sizes (ESr) and Spearman's correlation coefficient (r). Results: GPNMB expression was observed in 100 % of PT, and median 80 % (range 5-100 %) of tumour cells, VEGF in 92 % and 60 % (0-100 %), EGFR in 87 % and 60 % (0-100 %) respectively. In corresponding LNM, GPNMB expression was observed in 100 % of LNM and median 90 % (20-100 %) of tumour cells, VEGF in 87 % and 65 % (0-100 %), and EGFR in 84 % and 35 % (0-100 %). A positive correlation was found between expression in PT and LNM for GPNMB (r = 0.548) and EGFR (r = 0.618) (p < 0.001), but not for VEGF (r = -0.020; p = 0.905). GPNMB expression was present in a higher percentage of tumour cells compared to EGFR in PT (p = 0.015, ESr = -0.320) and in LNM (p <0.001, ESr = -0.478), while VEGF was not (p = 1.00, ESr = -0.109 and - 0.152, respectively). Conclusion: GPNMB expression is higher than EGFR in untreated HNSCC PT and corresponding LNM, while VEGF expression is comparable to EGFR. GPNMB is a promising target for fluorescent imaging in HNSCC.
引用
收藏
页数:5
相关论文
共 50 条
[31]   Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis [J].
Shiga, Kiyoto ;
Takahashi, Kohta ;
Sato, Ikuro ;
Kato, Kengo ;
Saijo, Shigeru ;
Moriya, Setsuko ;
Hosono, Masahiro ;
Miyagi, Taeko .
CANCER SCIENCE, 2015, 106 (11) :1544-1553
[32]   Sorafenib in squamous cell carcinoma of the head and neck: molecular basis and potential role [J].
Bhatt, Vijaya R. ;
Ganti, Apar Kishor .
FUTURE ONCOLOGY, 2014, 10 (01) :17-20
[33]   Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma [J].
Camacho, Mercedes ;
Vazquez-Lopez, Cristina ;
Valero, Cristina ;
Holgado, Anna ;
Terra, Ximena ;
Aviles-Jurado, Francesc Xavier ;
Leon, Xavier .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (12) :6637-6644
[34]   Effect of Reconstruction Parameters in High-Definition PET/CT on Assessment of Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma [J].
Sadick, Maliha ;
Molina, Flavia ;
Frey, Sabine ;
Piniol, Rafael ;
Sadick, Haneen ;
Brade, Joachim ;
Fink, Christian ;
Schoenberg, Stefan O. ;
He, Yong .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2013, 41 (01) :19-25
[35]   Gene targets of sulforaphane in head and neck squamous cell carcinoma [J].
Hu, Lanlin ;
Li, Hua ;
Lee, Eliot D. ;
Grandis, Jennifer R. ;
Bauman, Julie E. ;
Johnson, Daniel E. .
MOLECULAR MEDICINE REPORTS, 2019, 20 (06) :5335-5344
[36]   One-step nucleic acid amplification for detecting lymph node metastasis of head and neck squamous cell carcinoma [J].
Peigne, Lucie ;
Godey, Florence ;
Le Gallo, Mathieu ;
Le Gall, Francois ;
Fautrel, Alain ;
Morcet, Jeff ;
Jegoux, Franck .
ORAL ONCOLOGY, 2020, 102
[37]   Potential biomarkers for head and neck squamous cell carcinoma [J].
Brown, JJ ;
Xu, H ;
Nishitani, J ;
Mohammed, H ;
Osborne, R ;
Teklehaimanot, S ;
Gill, G ;
Liu, X .
LARYNGOSCOPE, 2003, 113 (03) :393-400
[38]   Immunohistochemistry, A Valuable Tool in Detection of Cervical Lymph Node Micrometastases in Head and Neck Squamous Cell Carcinoma: A Prospective Study [J].
Sharma, Anjani Kumar ;
Mishra, Prakash ;
Gupta, Shubha .
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2013, 65 :S89-S94
[39]   Infracentimetric cervical lymph node metastasis in head and neck squamous cell carcinoma: Incidence and prognostic value [J].
Pauzie, A. ;
Gavid, M. ;
Dumollard, J. -M. ;
Timoshenko, A. ;
Peoc'h, M. ;
Prades, J. -M. .
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2016, 133 (05) :307-311
[40]   Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary [J].
Martin, Jeffrey M. ;
Galloway, Thomas J. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (03) :579-+